ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.155,24
-0,04%
S&P 500
5.465,39
-0,07%
Dow Jones
39.145,93
0,09%
Euro vs US Dollar
1,0686
-0,22%
Bitcoin
61.231,44
-0,94%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Telesis Bio Inc (TBIO)

  7. Telesis Bio Inc (TBIO) News

TBIO

Telesis Bio (TBIO)

Telesis Bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TBIO
DatumZeitQuelleÜberschriftSymbolFirma
12/06/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
11/06/202402h40Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TBIOTelesis Bio Inc
11/06/202402h30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TBIOTelesis Bio Inc
10/05/202412h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBIOTelesis Bio Inc
09/05/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
09/05/202422h05GlobeNewswire Inc.Telesis Bio Reports First Quarter 2024 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
06/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
06/05/202422h05GlobeNewswire Inc.Telesis Bio Announces Reverse Stock SplitNASDAQ:TBIOTelesis Bio Inc
18/04/202415h00GlobeNewswire Inc.Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadershipNASDAQ:TBIOTelesis Bio Inc
28/03/202421h05GlobeNewswire Inc.Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
06/03/202400h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
06/03/202400h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
06/03/202400h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
01/03/202402h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
01/03/202402h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
26/02/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
26/02/202415h15GlobeNewswire Inc.Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
30/11/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
13/11/202322h32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBIOTelesis Bio Inc
13/11/202322h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
13/11/202322h22GlobeNewswire Inc.Telesis Bio Reports Third Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
09/11/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
07/11/202315h00GlobeNewswire Inc.Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023NASDAQ:TBIOTelesis Bio Inc
03/11/202317h00GlobeNewswire Inc.Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNANASDAQ:TBIOTelesis Bio Inc
24/10/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
28/09/202321h48GlobeNewswire Inc.Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGSNASDAQ:TBIOTelesis Bio Inc
22/09/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
29/08/202322h05GlobeNewswire Inc.Telesis Bio Appoints William J. Kullback Chief Financial OfficerNASDAQ:TBIOTelesis Bio Inc
29/08/202322h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
11/08/202312h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBIOTelesis Bio Inc
 Showing the most relevant articles for your search:NASDAQ:TBIO

Kürzlich von Ihnen besucht

USOTC
IMMPF
Immupharma (PK)
BIT
F33950
Vontobel Financial Produ...
BITMOT
809323
Obligaciones Tf 1,5% Ap2...
BIT
UR9ZNX
UniCredit Bank
NYSE
STT-C
State Street
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten